KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Change in Acquisitions & Divestments (2016 - 2025)

Historic Change in Acquisitions & Divestments for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to $422.2 million.

  • Ionis Pharmaceuticals' Change in Acquisitions & Divestments rose 1384.17% to $422.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 13.89%. This contributed to the annual value of $1.8 billion for FY2024, which is 1164.25% up from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Change in Acquisitions & Divestments of $422.2 million as of Q3 2025, which was up 1384.17% from $385.8 million recorded in Q2 2025.
  • Ionis Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $600.8 million for Q1 2024, and its period low was $178.8 million during Q1 2022.
  • Its 5-year average for Change in Acquisitions & Divestments is $367.9 million, with a median of $374.4 million in 2023.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first tumbled by 5658.32% in 2022, then soared by 10933.2% in 2023.
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Change in Acquisitions & Divestments stood at $292.3 million in 2021, then decreased by 23.01% to $225.1 million in 2022, then skyrocketed by 73.72% to $391.0 million in 2023, then increased by 9.96% to $429.9 million in 2024, then decreased by 1.79% to $422.2 million in 2025.
  • Its Change in Acquisitions & Divestments was $422.2 million in Q3 2025, compared to $385.8 million in Q2 2025 and $494.8 million in Q1 2025.